Description
This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements | HTML | Open resource | |
| Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements | HTML | Open resource |